Gold prices have reached a historic high of over $3,650, driven by anticipated Federal Reserve rate cuts and significant central bank gold reserve accumulation. Major investment banks forecast gold could reach $4,000 by mid-2026, with several gold mining companies positioning themselves to benefit from this trend.

Gold prices have been climbing, rekindling investor interest in junior mining companies. Several junior miners are reporting positive exploration results and advancing their projects, including RUA GOLD, Luca Mining, Probe Gold, Dakota Gold, and Montage Gold.

Gold prices have rebounded above $3,010, attracting investors back to mining stocks. Several gold miners, including Lake Victoria Gold, New Gold, Thor Explorations, Westgold Resources, and Dakota Gold, have reported positive developments, signaling a favorable outlook for the gold mining industry.

Donaldson, Atmus Filtration Technologies and Fuel Tech have been highlighted in this Industry Outlook article.

The Dow Jones index closed lower by over 50 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. AmeriServ Financial The Trade: AmeriServ Financial, Inc. (NASDAQ: ASRV) Director Richard W. Bloomingdale acquired a total of 1,783 shares an average price of $2.85. To acquire these shares, it cost around $5,086. What’s Happening: On ...

Top Stories for Feb. 15, 2024: 1. Morgan Stanley analyst Carlos De Alba downgraded United States Steel Corporation (NYSE: X) from Overweight to Equal-Weight and raised his price target from $40 to $51. Analyst Carlos De Alba also downgraded Cleveland-Cliffs (NYSE: CLF) from Overweight to Equal-Weight and lowered his price target from $21.50 to $20. 2. Cleveland-Cliffs announced that it will idle its tinplate production plant in Weirton, West Virginia, in April 2024 indefinitely. The decision is a direct result of the International Trade Commission (ITC) rejecting the addition of special tariffs and subsidies on tin mill products that were proposed by the Department of Commerce. Roughly 900 Cleveland-Cliffs employees impacted by the change will be allowed to relocate to other Cliffs facilities or offered severance packages. Cleveland-Cliffs' Chairman, President and Chief Executive Officer Lourenco Goncalves said, "In what was our final effort to maintain tinplate production here in America, we proved that we are forced to operate on an uneven playing field, and that the deck was stacked in favor of the importers. Despite the Department of Commerce finding evidence of dumping and subsidization from respondent countries, the ITC shockingly ruled against imposition of ...Full story available on Benzinga.com

The Dow Jones index closed higher by more than 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Lumen Technologies The Trade: Lumen Technologies, Inc. (NYSE: LUMN) Director James Fowler acquired a total of 33,500 shares an average price of ...

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. RBB Bancorp The Trade: RBB Bancorp (NASDAQ: RBB) Director ...

The Dow Jones recorded losses for the month of February. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. TrueCar The Trade: TrueCar, Inc. (NASDAQ: TRUE) Director Brendan Harrington bought a total of 10,400 shares at an average price of $2.45. To acquire these shares, it cost around $25.48 thousand. What’s Happening: TrueCar posted weaker-than-expected Q4 results. What TrueCar Does: TrueCar Inc is a data-driven online platform operating on ...

The Dow Jones closed lower by around 700 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Spruce Biosciences The Trade: Spruce Biosciences Inc (NASDAQ: SPRB) 10% owner Novo Holdings AS bought a total of 2,208,000 shares at an average price of $3.17. To acquire these shares, it cost around $7 million. What’s Happening: Spruce Biosciences announced a $53.6 million private placement financing. What Spruce Biosciences Does: Spruce ...

Upgrades According to TD Securities, the prior rating for John Hancock Financial Opportunities Fund (NYSE:BTO) was changed from Buy to Action List Buy. The stock has a 52-week-high of $52.88 and a 52-week-low of $31.95. At the end of the last trading period, John Hancock Finl Opps closed at $35.82. According to RBC Capital, the prior rating for Vale SA (NYSE:VALE) was changed from Sector Perform to Outperform. Vale earned $1.32 in the second quarter, compared to $1.49 in the year-ago quarter. The stock has a 52-week-high of $21.29 and a 52-week-low of $11.72. At the end of the last trading period, Vale closed at $13.51. According to Raymond James, the prior rating for Enbridge Inc (NYSE:ENB) was changed from Market Perform to Outperform. In the second quarter, Enbridge showed an EPS of $0.53, compared to $0.54 from the year-ago quarter. At the moment, the stock has a 52-week-high of $47.67 and a 52-week-low of $38.94. Enbridge closed at $41.82 at the end of the last trading period. B of A Securities upgraded the previous rating for Canadian Pacific Railway Ltd (NYSE:CP) from Neutral to Buy. In the second quarter, Canadian Pacific Railway showed an EPS of $0.74, compared to $0.84 from the year-ago quarter. The stock has a 52-week-high of $84.22 and a 52-week-low of $66.70. At the end of the last trading period, Canadian Pacific Railway closed at $78.29. According to B of A Securities, the prior rating for Canadian National Railway Co (NYSE:CNI) was changed from Neutral to Buy. For the second quarter, Canadian National Railway had an EPS of $1.51, compared to year-ago quarter EPS of $1.21. The current stock performance of Canadian National Railway shows a 52-week-high of $137.19 and a 52-week-low of $106.61. Moreover, at the end of the last trading period, the closing price was at $122.01. According to B of A Securities, the prior rating for Union Pacific Corp (NYSE:UNP) was changed from Neutral to Buy. Union Pacific earned $2.93 in the second quarter, compared to $2.72 in the year-ago quarter. At the moment, the stock has a 52-week-high of $278.94 and a 52-week-low of $202.38. Union Pacific closed at $231.88 at the end of the last trading period. For Telos Corp (NASDAQ:TLS), Wedbush upgraded the previous rating of Neutral to Outperform. In the second quarter, Telos showed an EPS of $0.04, compared to $0.04 from the year-ago quarter. The current stock performance of Telos shows a 52-week-high of $16.15 and a 52-week-low of $6.54. Moreover, at the end of the last trading period, the closing price was at $10.90. For Carpenter Technology Corp (NYSE:CRS), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Carpenter Tech had an EPS of $0.00, compared to year-ago quarter EPS of $0.28. The stock has a 52-week-high of $44.96 and a 52-week-low of $24.76. At the end of the last trading period, Carpenter Tech closed at $35.89. For Carvana Co (NYSE:CVNA), Piper Sandler upgraded the previous rating of Neutral to Overweight. In the second quarter, Carvana showed an EPS of $2.35, compared to $0.26 from the year-ago quarter. The current stock performance of Carvana shows a 52-week-high of $240.58 and a 52-week-low of $19.45. Moreover, at the end of the last trading period, the closing price was at $36.62. See all analyst ratings upgrades. Downgrades According to B of A Securities, the prior rating for Neoleukin Therapeutics Inc (NASDAQ:NLTX) was changed from Buy to Underperform. For the second quarter, Neoleukin Therapeutics had an EPS of $0.28, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $5.35 and a 52-week-low of $0.80. At the end of the last trading period, Neoleukin Therapeutics closed at $1.09. TD Securities downgraded the previous rating for Energy HBR Corp (OTC:ENGH) from Buy to Hold. At the moment, the stock has a 52-week-high of $77.25 and a 52-week-low of $46.55. Energy HBR closed at $77.25 at the end of the last trading period. Citigroup downgraded the previous rating for Occidental Petroleum Corp (NYSE:OXY) from Buy to Neutral. In the second quarter, Occidental Petroleum showed an EPS of $3.16, compared to $0.32 from the year-ago quarter. The current stock performance of Occidental Petroleum shows a 52-week-high of $77.13 and a 52-week-low of $29.15. Moreover, at the end of the last trading period, the closing price was at $65.61. Vertical Research downgraded the previous rating for Livent Corp (NYSE:LTHM) from Buy to Hold. Livent earned $0.37 in the second quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Livent shows a 52-week-high of $36.38 and a 52-week-low of $19.35. Moreover, at the end of the last trading period, the closing price was at $34.45. For Adobe Inc (NASDAQ:ADBE), Mizuho downgraded the previous rating of Buy to Neutral. In the second quarter, Adobe showed an EPS of $3.35, compared to $3.03 from the year-ago quarter. At the moment, the stock has a 52-week-high of $575.00 and a 52-week-low of $338.00. Adobe closed at $394.78 at the ...Full story available on Benzinga.com

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. IVERIC bio, Inc. (NASDAQ: ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). HyreCar Inc. (NASDAQ: HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. Spero Therapeutics, Inc. (NASDAQ: SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI). ChannelAdvisor Corporation (NYSE: ECOM) shares jumped 55% to settle at $22.79 after the company announced it will be acquired by CommerceHub for $23.10 per share. Akumin Inc. (NASDAQ: AKU) climbed 37% to close at $1.63. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement. Apexigen, Inc. (NASDAQ: APGN) rose 34.4% to close at $7.03. First Wave BioPharma, Inc. (NASDAQ: FWBI) shares gained 32.7% to close at $4.22 after gaining 7% on Friday. Galera Therapeutics, Inc. (NASDAQ: GRTX) jumped 29.5% to settle at $1.67. Galera Therapeutics, last month, posted a Q2 loss of $0.54 per share. HilleVax, Inc. (NASDAQ: HLVX) rose 24.8% to close at $17.05. HilleVax recently said Safety Data Monitoring Committee has recommended continuation of NEST-IN1 Phase 2b clinical trial. T Stamp Inc. (NASDAQ: IDAI) gained 24.6% to close at $1.72. Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) jumped 24.6% to close at $3.49. Avaya Holdings Corp. (NASDAQ: AVYA) gained 24% to close at $2.12. Avalo Therapeutics, Inc. (NASDAQ: AVTX) rose 22.3% to settle at $5.87. Avalo advanced BTLA agonist fusion protein (AVTX-008) to IND-enabling stage. BioVie Inc. (NASDAQ: BIVI) rose 21.6% to close at $3.44. Ainos, Inc. (NASDAQ: AIMD) gained 21.1% to close at $2.24. Ainos recently submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for conducting a Phase 2 trial of its drug candidate VELDONA, for treatment of mild symptoms related to COVID-19. Neonode Inc. (NASDAQ: NEON) jumped 18.7% to settle at $4.26. Neonode, last month, posted a Q2 loss of $0.11 per share. Grove Collaborative Holdings, Inc. (NYSE: GROV) gained 18.4% to close at $5.80. a.k.a. Brands Holding Corp. (NYSE: AKA) surged 17.4% to settle at $2.36. SelectQuote, Inc. (NYSE: SLQT) climbed 16.8% to settle at $1.11. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates. ADT Inc. (NYSE: ADT) rose 16.4% to close at $8.39 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google. Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 15.3% to close at $0.70. Dermata Therapeutics recently posted a Q2 loss of $0.24 per share Regulus Therapeutics Inc. (NASDAQ: RGLS) gained 14.1% to close at $1.62. Regulus Therapeutics, last ...